- KR₩181bn
- KR₩255bn
- KR₩254bn
Brief: Yungjin Pharm Q1 Operating Profit 2.6 Billion Won, Down 43% From Year Earlier
Brief: Yungjin Pharm Wins 99.5 Billion Won Order
Brief: Yungjin Pharm Q2 Operating Profit 1.2 Billion Won, Swings To Profit From Year Earlier
Brief: Yungjin Pharm Q1 Operating Profit 4.6 Billion Won, Up 755.5% From Year Earlier
Brief: Yungjin Pharm Q3 Operating Profit 320 Million Won, Swings To Profit From Year Earlier
Brief: Yungjin Pharm Q3 Operating Loss 2.3 Billion Won, Up 44% From Year Earlier
Brief: Yungjin Pharm To Invest 21.5 Billion Won In S.Korea Production Expansion
Brief: Yungjin Pharm signs contract worth 14.76 bln won
Brief: NeuroVive Pharmaceutical enters into global licensing agreement with Yungjin Pharm
Brief: Yungjin Pharm signs 181.56 bln won contract with Sawai Pharmaceutical
Brief: YUNGJIN PHARM IND to sell properties for 21.4 bln won